SCHEMBL4575151

SCHEMBL4575151

CC(C)c1ccc(N(CCCc2ccc(OCC(=O)O)cc2)Cc2ccc(OC(F)(F)F)cc2)nc1

nearest known ligand 0.44

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.44
LPAR1 Q92633 2/20 0.40
LPAR2 Q9HBW0 1/20 0.40
PPARD Q03181 3/20 0.39
PPARG P37231 1/20 0.39
PPARA Q07869 1/20 0.39
GAA P10253 1/20 0.39
TRPV1 Q8NER1 1/20 0.37
TSHR P16473 1/20 0.37
PTGIR P43119 1/20 0.37
TRPM8 Q7Z2W7 2/20 0.36
DAGLA Q9Y4D2 2/20 0.36
LTB4R2 Q9NPC1 2/20 0.36
PTPN1 P18031 1/20 0.36
FFAR1 O14842 1/20 0.35
FFAR4 Q5NUL3 1/20 0.35
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4575379 0.92 PTGDR2 (0.44) ALDH1A1LPAR1LPAR2PPARDPPARG
SCHEMBL4575250 0.90 PPARA (0.48) PPARDPPARGPPARA
SCHEMBL4575472 0.88 CETP (0.37) ALDH1A1PPARDPPARGPPARATRPM8
SCHEMBL4575291 0.87 LMNA (0.40) ALDH1A1TSHRMEN1KMT2A
SCHEMBL4575393 0.86 CA12 (0.40) ALDH1A1PPARDPPARGPPARAGAA
SCHEMBL4575605 0.85 PPARA (0.48) ALDH1A1PPARDPPARGPPARATRPM8
SCHEMBL14277961 0.84 PPARD (0.49) PPARDPPARGPPARA
SCHEMBL4575304 0.83 PPARA (0.48) PPARDPPARGPPARA
SCHEMBL4575888 0.83 PPARG (0.45) PPARDPPARGPPARA
SCHEMBL4575418 0.83 PPARG (0.46) PPARDPPARGPPARA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7319104-B2 hPPARs activators SMITHKLINE BEECHAM CORPORATION (US) 2008-01-15 US disclosed
US-7319104-B2 hPPARs activators SMITHKLINE BEECHAM CORPORATION (US) 2008-01-15 US disclosed
US-7319104-B2 hPPARs activators SMITHKLINE BEECHAM CORPORATION (US) 2008-01-15 US disclosed
US-20050137212-A1 Hppars activators SMITHKLINE BEECHAM CORPORATION 2005-06-23 US disclosed
EP-1480957-A1 HPPARS ACTIVATORS SMITHKLINE BEECHAM CORPORATION (US) 2004-12-01 EP disclosed
WO-2003074495-A1 HPPARS ACTIVATORS SMITHKLINE BEECHAM CORPORATION (US) 2003-09-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050137212-A1 Hppars activators PPARG, PPARA, PPARD ALDH1A1 645/4885LPAR1 380/4885LPAR2 619/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.